| HR (95% CI) | P value | Global Chi-square | C-statistic | C-statistic P value | Continuous NRI | NRI P value | Absolute IDI | IDI P value |
---|---|---|---|---|---|---|---|---|---|
Clinical predictor + CT-FFR ≤ 0.80 (model 1) |  |  | 25.79 | 0.633 | - | - | - | - | - |
Diabetes mellitus | 1.517 (1.005–2.289) | 0.047 |  |  |  |  |  |  |  |
CT-FFR ≤ 0.80 | 2.512 (1.667–3.786) | 0.000 |  |  |  |  |  |  |  |
model 1 + FAI[LAD] ≥ 70.1 (model 2) |  |  | 30.72 | 0.643 | 0.054 (vs. model 1) | 0.041 (-0.141-0.187) | 0.189 (vs. model 1) | 0.005 (-0.002-0.031) | 0.259 (vs. model 1) |
Diabetes mellitus | 1.502 (0.995–2.267) | 0.053 |  |  |  |  |  |  |  |
CT-FFR ≤ 0.80 | 2.486 (1.649–3.748) | 0.000 |  |  |  |  |  |  |  |
FAI[LAD] ≥ −70.1 | 2.101 (1.055–4.182) | 0.035 |  |  |  |  |  |  |  |
model 1 + FAI[LCX] ≥ 70.1 (model 3) |  |  | 52.08 | 0.669 | < 0.001 (vs. model 1) | 0.161 (0.073–0.260) | < 0.001 (vs. model 1) | 0.036 (0.008–0.090) | = 0.010 (vs. model 1) |
Diabetes mellitus | 1.461 (0.968–2.207) | 0.071 |  |  |  |  |  |  |  |
CT-FFR ≤ 0.80 | 2.442 (1.619–3.683) | 0.000 |  |  |  |  |  |  |  |
FAI[LCX] ≥ −70.1 | 3.230 (1.982–5.265) | 0.000 |  |  |  |  |  |  |  |